Aug. 27, 2020 / Ameriderm Research
This trial is for patients aged 18 and older with moderate to severe prurigo nodularis clinically diagnoses for over 6 months. It involves administering injected medication. This is as a double-blind, randomized, placebo treatments controlled for 16 weeks with an 8 week follow up. A possible long term extension may follow the initial trial.
The trial is expected to enroll quickly.
CALL TODAY (386) 523-0768 to see if you qualify.